Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 GSK PHARMA   TEVA PHARMA
EQUITY SHARE DATA
    GSK PHARMA
Mar-23
TEVA PHARMA
Dec-13
GSK PHARMA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,6843,489-   
Low Rs1,2313,031-   
Sales per share (Unadj.) Rs191.92,002.2-  
Earnings per share (Unadj.) Rs35.9125.1-  
Cash flow per share (Unadj.) Rs39.8286.9-  
Dividends per share (Unadj.) Rs32.00109.49-  
Avg Dividend yield %2.23.4 65.4%  
Book value per share (Unadj.) Rs102.92,224.0-  
Shares outstanding (eoy) m169.41848.00-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.61.6 466.3%   
Avg P/E ratio x40.626.1 155.9%  
P/CF ratio (eoy) x36.711.4 322.7%  
Price / Book Value ratio x14.21.5 966.4%  
Dividend payout %89.287.5 101.9%   
Avg Mkt Cap Rs m246,8582,764,158 8.9%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m5,9500-   
Avg. sales/employee Rs Th037,776.0-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th02,359.8-  
INCOME DATA
Net Sales Rs m32,5171,697,844 1.9%  
Other income Rs m1,0070-   
Total revenues Rs m33,5241,697,844 2.0%   
Gross profit Rs m8,033464,956 1.7%  
Depreciation Rs m658137,238 0.5%   
Interest Rs m1833,348 0.1%   
Profit before tax Rs m8,364294,369 2.8%   
Minority Interest Rs m01,337 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-193,237 -0.0%   
Tax Rs m2,288-3,594 -63.7%   
Profit after tax Rs m6,076106,063 5.7%  
Gross profit margin %24.727.4 90.2%  
Effective tax rate %27.4-1.2 -2,240.2%   
Net profit margin %18.76.2 299.1%  
BALANCE SHEET DATA
Current assets Rs m24,9431,146,718 2.2%   
Current liabilities Rs m13,2641,000,035 1.3%   
Net working cap to sales %35.98.6 415.7%  
Current ratio x1.91.1 164.0%  
Inventory Days Days9791 107.2%  
Debtors Days Days21696 225.1%  
Net fixed assets Rs m6,988554,553 1.3%   
Share capital Rs m1,6944,179 40.5%   
"Free" reserves Rs m15,7350-   
Net worth Rs m17,4301,885,983 0.9%   
Long term debt Rs m0868,145 0.0%   
Total assets Rs m31,9303,880,118 0.8%  
Interest coverage x462.69.8 4,707.3%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x1.00.4 232.7%   
Return on assets %19.13.6 531.2%  
Return on equity %34.95.6 619.9%  
Return on capital %48.14.9 975.2%  
Exports to sales %00-   
Imports to sales %48.10-   
Net fx Rs m-14,0080-   
CASH FLOW
From Operations Rs m4,842270,548 1.8%  
From Investments Rs m8,079-95,866 -8.4%  
From Financial Activity Rs m-15,433-324,541 4.8%  
Net Cashflow Rs m-2,512-149,859 1.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 83.58 Rs / USD

Compare GSK PHARMA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare GSK PHARMA With: KIMIA BIOSCIENCES  DESH RAKSHAK  AUROBINDO PHARMA  HINDUSTAN BIOSCIE  NATURAL CAPS  



Today's Market

Sensex Today Rallies 599 Points | Private Banks Rally | 4 Reasons Why Indian Share Market is Rising Sensex Today Rallies 599 Points | Private Banks Rally | 4 Reasons Why Indian Share Market is Rising(Closing)

After opening the day deep in red, Indian share markets reversed the trend as the session progressed and ended on firm footing.